ORIC — ORIC Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for ORIC Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	89.2	294	237	206	208
Prepaid Expenses
Total Current Assets	90	297	241	210	213
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.24	1.98	2.41	3.25	2.86
Long Term Investments
Other Long Term Assets
Total Assets	94.1	299	299	247	252
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	5.35	9	15.2	15.4	20.5
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	6.12	9.22	25.7	24.8	27.9
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	88	290	273	222	224
Total Liabilities & Shareholders' Equity	94.1	299	299	247	252
Total Common Shares Outstanding